Skip to main content
. 2021 Sep 27;13(19):4830. doi: 10.3390/cancers13194830
DDX DEAD-box RNA Helicases
TNBC triple-negative breast cancer
IC50 half-maximal inhibitory concentration
ER estrogen receptor
PR progesterone receptor
HER2 human epidermal growth factor receptor 2
TCF/LEF T cell factor/lymphoid enhancer factor
i.v. intra-venous
i.p. intra-peritoneal
p.o. per os.